MIT Center for Biomedical Innovation
CBI: Advancing global health through collaborative biomedical innovation and research.
Founded
2005CBI: Advancing global health through collaborative biomedical innovation and research.
Founded within the Massachusetts Institute of Technology (MIT), the MIT Center for Biomedical Innovation (CBI) aims to improve global health by addressing challenges in biomedical innovation. CBI fosters a collaborative research environment that includes industry, academia, and government, leveraging expertise from MIT's Schools of Engineering, Science, and Management, as well as the Harvard-MIT Division of Health Sciences and Technology (HST). The center focuses on developing and implementing new biomedical technologies and solutions to enhance healthcare outcomes worldwide.
Notable affiliates include leading researchers and faculty from MIT and Harvard, contributing to CBI's interdisciplinary approach. The center has achieved significant milestones in facilitating groundbreaking research and fostering partnerships that drive innovation. By providing a transparent and safe space for collaboration, CBI has made a substantial impact on the biomedical field, accelerating the development of new treatments and technologies that address pressing global health issues.
Companies similar to MIT Center for Biomedical Innovation include Novartis Institutes For Biomedical Research, Amit Technion, MIT Energy Initiative and Michigan Institute for Clinical & Health Research.
MIT Center for Biomedical Innovation was founded in 2005.
MIT Center for Biomedical Innovation's headquarters is located in Cambridge, MA, US.
MIT Center for Biomedical Innovation's most recent funding round was for $10.4M (USD) in October 2013.
As of Oct 5, 2013, MIT Center for Biomedical Innovation has disclosed funding of $10.4M (USD). Undisclosed round amounts are excluded.
MIT Center for Biomedical Innovation has 7,500 employees as of Feb 4, 2024.
Michigan Institute for Clinical & Health Research
michr.umich.edu
